An article introducing the business partnership between Elix, Inc. and PRISM BioLab Co., Ltd. was published in the online edition of Nikkei on April 11, 2025.

This partnership aims to accelerate the discovery of promising compounds and improve the efficiency of drug development by combining Elix’s AI technologies with PRISM BioLab’s proprietary technology.

▼The article can be accessed at the following link (Japanese only; Nikkei subscription required):
PRISM BioLab and AI Drug Discovery Startup Collaborate for Efficient Drug Development